|
Market Cap (5-Jun) $19,084,808 (1,108th) |
Close (30-Jun) $0.042 |
Volume (30-Jun) 149,220 |
Shortsold (10-Feb) 15,546 (0.00%) (581st) |
|
52w High $0.059 |
52w Low $0.033 |
P/E 15.29 |
EPS 0 |
RHT released this announcement to the ASX on 11 December 2020, 15:18. The announcement is not marked as price sensitive, and is 16 page(s) in length and 385.6kb in size.
You can view all announcements from RHT and see how they appear on a price chart on the announcements page.
At the date of this announcement, RHT was 0.038% short sold according to ASIC data. It was ranked the 487th most shorted stock on the ASX. It remains ranked 581st as of the latest reported data (10 February 2025).
| Other Recent Announcements from RHT | |
|---|---|
| Receipt of R&D Tax Incentive Refund | 30 June 2023, 12:22 |
| Updated HepaFatSmart Cleared by US FDA | 29 June 2023, 11:04 |
| Management Transition | 23 June 2023, 8:18 |
| Secondary Trading Notice & Appendix 2A | 11 December 2020, 15:18 |
| HepaFat-AI gains US FDA clearance | 9 December 2020, 10:23 |
| Trading Halt | 8 December 2020, 10:49 |
| Pause in Trading | 8 December 2020, 10:36 |
You must be logged in to post a reply.
Resonance Health 